Philippe Morlat

发表

Liver‐related deaths in HIV‐infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 Study in collaboration with the Mortalité 2005 survey, ANRS EN19) *

P. Morlat, D. Costagliola, C. Lewden, 2009, HIV medicine.

Prevalence of cutaneous disorders in a population of HIV-infected patients. Southwestern France, 1996. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

P. Morlat, F. Dabis, M. Doutre, 1998, Archives of dermatology.

Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. The Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

J. Ragnaud, M. Dupon, P. Morlat, 1992, AIDS.

Management of chronic hepatitis C in French departments of internal medicine and infectious diseases

F. Carrat, D. Ouzan, P. Morlat, 2005, Epidemiology and Infection.

Prevalence and factors associated with renal impairment in HIV‐infected patients, ANRS C03 Aquitaine Cohort, France

D. Neau, S. Lawson-Ayayi, M. Dupon, 2010, HIV medicine.

Dual Nucleoside Regimens in Nonadvanced HIV Infection: Prospective Follow‐Up of 130 Patients, Aquitaine Cohort, 1996 to 1998

D. Neau, P. Morlat, L. Dequae-Merchadou, 2000, Journal of acquired immune deficiency syndromes.

Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study.

A. Mocroft, O. Kirk, A. Schultze, 2018, The Journal of infection.

Reference curves for CD4 T‐cell count response to combination antiretroviral therapy in HIV‐1‐infected treatment‐naïve patients

A. Mocroft, A. d’Arminio Monforte, C. Sabin, 2017, HIV medicine.

Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.

B. Luft, J. Fuhrer, C. Leport, 1993, The New England journal of medicine.

Non-acquired immune deficiency syndrome-defining malignancies in a hospital-based cohort of human immunodeficiency virus-infected patients: Bordeaux, France, 1985-1991. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

M. Dupon, P. Morlat, F. Dabis, 1992, Journal of the National Cancer Institute.

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV‐positive persons version 9.0

S. McCormack, A. Mocroft, O. Kirk, 2018, HIV medicine.

Liver‐related deaths in HIV‐infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey

P. Morlat, D. Costagliola, G. Chêne, 2015, HIV medicine.

Menopause and HIV infection: age at onset and associated factors, ANRS CO3 Aquitaine cohort

D. Neau, S. Lawson-Ayayi, P. Morlat, 2011, International journal of STD & AIDS.

Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.

D. Podzamczer, C. Katlama, H. Furrer, 2012, The Journal of antimicrobial chemotherapy.

HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients.

D. Neau, P. Morlat, F. Dabis, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV‐infected patients

R. Salamon, B. Luft, P. Morlat, 1996, AIDS.

Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group.

R. Salamon, B. Luft, C. Leport, 1998, Controlled clinical trials.

Carotid intima–media thickness is slightly increased over time in HIV‐1‐infected patients *

D. Neau, S. Lawson-Ayayi, M. Dupon, 2005, HIV medicine.

Trends and determinants of severe morbidity in HIV‐infected patients: the ANRS CO3 Aquitaine Cohort, 2000–2004 *

S. Lawson-Ayayi, M. Dupon, P. Morlat, 2007, HIV medicine.

Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV‐coinfected patients

D. Neau, P. Morlat, F. Dabis, 2011, Journal of viral hepatitis.

Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.

M. Dupon, P. Morlat, J. Pellegrin, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients.

P. Morlat, W. Rozenbaum, F. Raffi, 2000, The Journal of infectious diseases.

Menopause and HIV infection: age at onset and associated factors, ANRS CO3 Aquitaine cohort

D. Neau, S. Lawson-Ayayi, F. Dabis, 2011, International journal of STD & AIDS.